Abstract
RATIONALE: A targeted fractionation scheme was developed to simplify efforts aimed at identification of the chemical constituents most responsible for the therapeutic effects of ASHMI. The fractions showing the greatest inhibition of TNF-α release from LPS-stimulated macrophages were chosen for isolation and structural characterization studies.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
